Protagonist Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Protagonist Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Protagonist Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Protagonist Therapeutics Inc. is PTGX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Protagonist Therapeutics Inc. has its primary listing on NASDAQ. You can trade Protagonist Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Protagonist Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Protagonist Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Protagonist Therapeutics Inc..